A new drug for neutrocytopenia on successful development in Korea.

Published: 1999-03-16 10:56:00

Updated: 1999-03-16 10:56:00

Dong-A pharmaceutical company (President : Yoo Choong-shik) announced recently that Leucosteam, a new drug for treatment of neutrocytopenia, G-CSF, had been successfully developed for the first time in Korea and the 3rd in the world, by spending 4 billion Won of R&D investment for 6 years from 19...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK